ONC Q2 2024 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q2 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$929M+56.1% YoY

Gross Profit

$791M85.1% margin

Operating Income

-$107M-11.5% margin

Net Income

-$120M-13.0% margin

EPS (Diluted)

$-1.15

QoQ Revenue Growth

+23.6%

Cash Flow

Operating Cash Flow

-$96M

Free Cash Flow

-$206M

Stock-Based Comp.

$131M

Balance Sheet

Total Assets

$5.7B

Total Liabilities

$2.3B

Stockholders' Equity

$3.4B

Cash & Equivalents

$2.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$929M	$595M	+56.1%
Gross Profit	$791M	$499M	+58.4%
Operating Income	-$107M	-$319M	+66.4%
Net Income	-$120M	-$381M	+68.4%